The allure of tumor-released chemotactic factors beckons neutrophils to the tumor site, where tumor-associated neutrophils (TANs) can bolster CD8 + T cell responses and anti-tumor activity in the absence of tumor-derived TGF-β. Here, TGFB1 is linked to neoplasm.